Each filer's latest filing for 03589W102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
FMR LLC
13G/A
|
13.9% |
11/5/2026
Event 9/30/2026
|
||
| FMR LLC | 13.9% | |||
| Abigail P. Johnson | 13.9% | |||
|
Redmile Group, LLC
13G/A
|
9.9% |
7/8/2026
Event 7/1/2026
|
||
| Redmile Group, LLC | 9.9% | |||
| Jeremy C. Green | 9.9% | |||
| RedCo II Offshore SPV LLC | 5.5% | |||
| BlackRock, Inc. 13G/A | 8.0% |
7/27/2026
Event 6/30/2026
|
||
| Satter Muneer A 13D/A | 7.2% |
11/21/2025
Event 11/19/2025
|
||
| State Street Corp 13G | 6.0% |
8/7/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
|
Bain Capital Life Sciences Fund, L.P.
13G/A
|
4.9% |
2/14/2025
Event 12/31/2024
|
||
| BCLS I Investco, LP | 4.9% | |||
| BCIP Life Sciences Associates, LP | 0% | |||
| Bain Capital Life Sciences Fund, L.P. | 0% | |||
|
Biotechnology Value Fund L P
13G/A
|
4.4% |
11/16/2026
Event 9/30/2026
|
||
| Biotechnology Value Fund L P | 2.3% | |||
| BVF I GP LLC | 2.3% | |||
| Biotechnology Value Fund II LP | 1.7% | |||
| BVF II GP LLC | 1.7% | |||
| Biotechnology Value Trading Fund OS LP | 0.3% | |||
| BVF Partners OS Ltd. | 0.3% | |||
| BVF GP Holdings LLC | 4.0% | |||
| BVF Partners L P/IL | 4.4% | |||
| BVF Inc/IL | 4.4% | |||
| Lampert Mark N | 4.4% | |||
|
Point72 Asset Management, L.P.
13G/A
|
0.1% |
5/15/2025
Event 3/31/2025
|
||
| Point72 Asset Management, L.P. | 0.1% | |||
| Point72 Capital Advisors, Inc. | 0.1% | |||
| Steven A. Cohen | 0.1% | |||
|
Logos Global Management LP
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| Logos Global Management LP | 0% | |||
| Logos Global Management GP LLC | 0% | |||
| Logos Global Master Fund LP | 0% | |||
| Logos GP LLC | 0% | |||
| Arsani William | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 211 | 196 M | $830M |
| 2026 Q2 | 218 | 178 M | $1.02B |
| 2026 Q1 | 219 | 156 M | $865M |
| 2025 Q4 | 168 | 137 M | $687M |
| 2025 Q3 | 144 | 101 M | $309M |
| 2025 Q2 | 130 | 99.7 M | $239M |
| 2025 Q1 | 150 | 99.8 M | $192M |
| 2024 Q4 | 154 | 112 M | $575M |
| 2024 Q3 | 144 | 110 M | $651M |
| 2024 Q2 | 145 | 108 M | $527M |
| 2024 Q1 | 131 | 95.0 M | $680M |
| 2023 Q4 | 102 | 80.8 M | $366M |
| 2023 Q3 | 95 | 53.6 M | $126M |
| 2023 Q2 | 97 | 54.1 M | $190M |
| 2023 Q1 | 102 | 54.0 M | $208M |
| 2022 Q4 | 87 | 48.5 M | $244M |
| 2022 Q3 | 74 | 47.6 M | $292M |
| 2022 Q2 | 80 | 38.4 M | $145M |
| 2022 Q1 | 104 | 39.0 M | $107M |
| 2021 Q4 | 100 | 38.8 M | $446M |
| 2021 Q3 | 84 | 38.1 M | $709M |
| 2021 Q2 | 76 | 38.9 M | $874M |
| 2021 Q1 | 74 | 37.4 M | $1.04B |
| 2020 Q4 | 72 | 36.2 M | $904M |
| 2020 Q3 | 68 | 34.8 M | $1.04B |